Literature DB >> 24578246

Hilar cholangiocarcinoma: no longer hopeless.

Charles B Rosen1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24578246     DOI： 10.1007/s10620-014-3067-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Liver transplantation for cholangiocarcinoma: results in 207 patients.

Authors:  C G Meyer; I Penn; L James
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

2.  Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation.

Authors:  Jason M Ali; Luca Bonomo; Rebecca Brais; William J H Griffiths; David J Lomas; Emmanuel L Huguet; Raaj K Praseedom; Neville V Jamieson; Asif Jah
Journal:  Transplantation       Date:  2011-06-27       Impact factor: 4.939

3.  Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?

Authors:  Charles B Rosen; Sarwa Darwish Murad; Julie K Heimbach; Scott L Nyberg; David M Nagorney; Gregory J Gores
Journal:  J Am Coll Surg       Date:  2012-05-22       Impact factor: 6.113

4.  Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.

Authors:  Gregory J Gores; Robert G Gish; Debra Sudan; Charles B Rosen
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

5.  Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.

Authors:  I De Vreede; J L Steers; P A Burch; C B Rosen; L L Gunderson; M G Haddock; L Burgart; G J Gores
Journal:  Liver Transpl       Date:  2000-05       Impact factor: 5.799

6.  Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000.

Authors:  Reena J Salgia; Amit G Singal; Sherry Fu; Shawn Pelletier; Jorge A Marrero
Journal:  Dig Dis Sci       Date:  2013-03-16       Impact factor: 3.199

7.  Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

Authors:  Sarwa Darwish Murad; W Ray Kim; Denise M Harnois; David D Douglas; James Burton; Laura M Kulik; Jean F Botha; Joshua D Mezrich; William C Chapman; Jason J Schwartz; Johnny C Hong; Jean C Emond; Hoonbae Jeon; Charles B Rosen; Gregory J Gores; Julie K Heimbach
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

8.  Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.

Authors:  Peter Ghali; Paul J Marotta; Eric M Yoshida; Vincent G Bain; Denis Marleau; Kevork Peltekian; Peter Metrakos; Marc Deschênes
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

9.  Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.

Authors:  Debra Sudan; Arnaud DeRoover; Srinath Chinnakotla; Ira Fox; Byers Shaw; Tim McCashland; Mike Sorrell; Margaret Tempero; Alan Langnas
Journal:  Am J Transplant       Date:  2002-09       Impact factor: 8.086
  9 in total
  1 in total

1.  Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.

Authors:  Yaoting Chen; Huiqing Li; Xiongying Jiang; Dong Chen; Jiayan Ni; Hongliang Sun; Jianghong Luo; Herui Yao; Linfeng Xu
Journal:  Eur Radiol       Date:  2016-01-28       Impact factor: 5.315
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.